A detailed history of Re Dickinson Investment Advisors, LLC transactions in Gilead Sciences, Inc. stock. As of the latest transaction made, Re Dickinson Investment Advisors, LLC holds 30 shares of GILD stock, worth $2,642. This represents 0.0% of its overall portfolio holdings.

Number of Shares
30
Holding current value
$2,642
% of portfolio
0.0%

Shares

1 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 09, 2024

BUY
$63.15 - $72.88 $1,894 - $2,186
30 New
30 $2,000

Others Institutions Holding GILD

About GILEAD SCIENCES, INC.


  • Ticker GILD
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 1,253,369,984
  • Market Cap $110B
  • Description
  • Gilead Sciences, Inc., a biopharmaceutical company, discovers, develops, and commercializes medicines in the areas of unmet medical need in the United States, Europe, and internationally. The company provides Biktarvy, Genvoya, Descovy, Odefsey, Truvada, Complera/ Eviplera, Stribild, and Atripla products for the treatment of HIV/AIDS; Veklury, a...
More about GILD
Track This Portfolio

Track Re Dickinson Investment Advisors, LLC Portfolio

Follow Re Dickinson Investment Advisors, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Re Dickinson Investment Advisors, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Re Dickinson Investment Advisors, LLC with notifications on news.